RecruitingNCT06263439

Surveillance of HFMD in Pediatric Outpatients

Prospective Clinico-virological Surveillance of Diseases Foot-hand-mouth/Herpangina Associated With Enteroviruses in Pediatric Outpatients


Sponsor

University Hospital, Clermont-Ferrand

Enrollment

3,000 participants

Start Date

Jun 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The aims of this prospective multicentric study is to determine the types of enteroviruses (EVs) responsible for hand, foot and mouth disease (HFMD) or herpangina in children seen within an ambulatory setting : * to detect an EV-A71 epidemic or another type associated with atypical forms of the disease at an early stage * to describe and compare the epidemiological, demographic, clinical and virological characteristics of these infections between the different types of EV.


Eligibility

Max Age: 10 Years

Inclusion Criteria1

  • Children aged 0 to 10 years presenting with HFMD or herpangina

Exclusion Criteria2

  • Refusal to participate by holders of parental authority
  • Refusal to participate for children over 3 years of age

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTThroat/buccal swab sample

The study involves the genome detection of enteroviruses in throat or mouth swabs taken from children with a diagnosis of HFMD or herpangina. If positive, the precise type of enterovirus responsible will be identified by sequencing a viral genomic region.


Locations(1)

CHU de Clermont-Ferrand

Clermont-Ferrand, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06263439


Related Trials